Physician profile
Gregory R Vorhoff
NPI 1003815903
$910.50
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.31 · 2020: $110 · 2022: $135 · 2023: $528 · 2024: $97.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $160.78 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $160.47 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $96.39 | 2023-2024 | Camzyos, Eliquis |
| Amgen INC. | $90.31 | 2020-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.23 | 2022-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $78.22 | 2022-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $50.59 | 2023 | Tezspire, Farxiga, Fasenra |
| Abbott Laboratories | $40.31 | 2019 | |
| Pfizer INC. | $31.48 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $30.58 | 2023 | Dupixent |
| Novo Nordisk INC | $24.86 | 2023 | Ozempic |
| Kiniksa Pharmaceuticals, LTD. | $16.25 | 2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $15.87 | 2023 | Optimizer |
| Philips North America LLC | $15.36 | 2023 | |
| Jazz Pharmaceuticals INC. | $12.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Vorhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.